RHOA and neoplasm: Fifty‐one candidate proteins were identified, and we selected three top‐ranked, tumor‐related candidates (STK33, CLCN3, and RhoA) from the top 15 ranked proteins for further validation using SPR assays (Figure S1A, Supporting Information).